Treatment of prostate cancer

Details for Australian Patent Application No. 2010279398 (hide)

Owner Tokai Pharmaceuticals, Inc.

Inventors Morrison, Jodie Pope; Stein, Cy Aaron; Casebier, David Scott

Agent Cullens

Pub. Number AU-A-2010279398

PCT Pub. Number WO2011/017534

Priority 61/261,265 13.11.09 US; 61/232,257 07.08.09 US

Filing date 5 August 2010

Wipo publication date 10 February 2011

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/4184 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 March 2012 PCT application entered the National Phase

  PCT publication WO2011/017534 Priority application(s): WO2011/017534

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010279402-N1-acyl-5-fluoropyrimidinone derivatives

2010279391-Personal carrier-mounted dog leash with distal stiffener